Package 62135-501-30

Brand: ultramicrosize griseofulvin

Generic: ultramicrosize griseofulvin
NDC Package

Package Facts

Identity

Package NDC 62135-501-30
Digits Only 6213550130
Product NDC 62135-501
Product ID 62135-501_2e9858c1-8c99-8a0d-e063-6294a90a59a5
Description

30 TABLET in 1 BOTTLE (62135-501-30)

Marketing

Marketing Status
Marketed Since 2025-01-30
Brand ultramicrosize griseofulvin
Generic ultramicrosize griseofulvin
Sample Package No

Linked Drug Pages (1)

ULTRAMICROSIZE GRISEOFULVIN ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "2e9858c1-8c99-8a0d-e063-6294a90a59a5", "openfda": {"nui": ["N0000008732", "N0000175085", "N0000175848"], "upc": ["0362135501303"], "unii": ["32HRV3E3D5"], "rxcui": ["245248"], "spl_set_id": ["640c489e-f491-4805-a390-ef4be43e261b"], "pharm_class_pe": ["Decreased Mitosis [PE]", "Microtubule Inhibition [PE]"], "pharm_class_epc": ["Tubulin Inhibiting Agent [EPC]"], "manufacturer_name": ["Chartwell RX, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (62135-501-30)", "package_ndc": "62135-501-30", "marketing_start_date": "20250130"}], "brand_name": "ULTRAMICROSIZE GRISEOFULVIN", "product_id": "62135-501_2e9858c1-8c99-8a0d-e063-6294a90a59a5", "dosage_form": "TABLET", "pharm_class": ["Decreased Mitosis [PE]", "Microtubule Inhibition [PE]", "Tubulin Inhibiting Agent [EPC]"], "product_ndc": "62135-501", "generic_name": "ULTRAMICROSIZE GRISEOFULVIN", "labeler_name": "Chartwell RX, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ULTRAMICROSIZE GRISEOFULVIN", "active_ingredients": [{"name": "GRISEOFULVIN", "strength": "165 mg/1"}], "application_number": "ANDA061996", "marketing_category": "ANDA", "marketing_start_date": "19820406", "listing_expiration_date": "20261231"}